SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-24-014670
Filing Date
2024-11-19
Accepted
2024-11-19 17:14:15
Documents
6
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q endra_10q.htm 10-Q 631255
2 EMPLOYMENT AGREEMENT endra_ex101.htm EX-10.1 31796
3 CERTIFICATION endra_ex311.htm EX-31.1 9197
4 CERTIFICATION endra_ex312.htm EX-31.2 10847
5 CERTIFICATION endra_ex321.htm EX-32.1 4349
6 endra_ex101img1.jpg GRAPHIC 6174
  Complete submission text file 0001654954-24-014670.txt   697269
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37969 | Film No.: 241477270
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)